Bo Zhang

Discovery of Ziresovir as a Potent, Selective and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor.

J. Wu, Bo Zhang, Lisha Wang, 2019, Journal of medicinal chemistry.

Brain Structure Measurements Predict Individualized Treatment Outcome of 12-Week Antipsychotic Monotherapies in First-episode Schizophrenia.

H. Cao, H. Deng, Shanming Liu, 2023, Schizophrenia bulletin.

Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia

Shanming Liu, Zhuoqiu Zhang, Shui-chao Li, 2024, Translational psychiatry.